Peter A. Smars, M.D.
Associate Professor of Emergency, Medicine Mayo Clinic, Rochester MN

Peter Smars, MD, Associate Professor of Emergency, Medicine Mayo Clinic, Rochester MN, is currently in the process of seeking full endorsement by Mayo Clinic as a principal investigator of implementing a prospective research project  of using the Mesuron’s MagnetoCardioGraph (MCG) Avalon-H90 for evaluation of patients presenting with Acute Chest Pain to the ED.

Peter has extensive experience in evaluating various kinds of MCG devices from several different  companies. Peter has a long term relationship with Mesuron’s founder Mr. Bakharev investigating one of his previously developed MCG devices.

 Here is his opinion about MCG technology:

 “I think, potentially, MagnetoCardioGraphy would be very helpful in hospital’s emergency departments for several reasons. One, time to deliver the service for the patient, which for Acute Coronary Syndrome patients may mean quicker revascularization and saved heart muscle. Additionally, shorter time to disposition, whether admitted or discharged, which means less consumption of resources hence reduced cost, and possibly reduction in hospitalization rates, including observation with the same reduction in resource utilization and cost.”

He also mentioned:

“Mayo’s stand on orders of priorities has always been that that the most important factor is quality of care. In this case the most important thing we would be looking for is time and accuracy to arrive to diagnosis. Somebody said “time is heart muscle”, in other words in this case, if you can arrive with a high degree of accuracy of diagnosis in a suspect acute coronary syndrome in a very short time, like you potentially can with MCG compared with a regular ECG and awaiting the results of troponins (excluding STEMI’s of course), a patient may be going to the Cathlab very quickly and hence potentially saving heart muscle. Of secondary priority, “time is money” is also true as a quicker disposition is cheaper as less resources are being consumed. So this would be the secondary benefit.”

Additional information